Crescent Capital BDC (NASDAQ:CCAP) reported second-quarter net investment income of $0.36 per share, exceeding its $0.34 per-share base dividend but declining from $0.38 per share in the prior quarter excluding a one-time incentive-fee waiver.
The business development company’s net asset value fell to $17.82 per share as of June 30 from $18.27 at the end of the first quarter. Chief Executive Officer Jason Breaux said the decline was primarily tied to unrealized losses on non-accrual investments that the company is actively managing.
During the quarter, the company paid the first of three previously announced special dividends of $0.03 per share. Its board also declared a regular third-quarter dividend of $0.34 per share, along with the second $0.03 special dividend, to be paid Sept. 15. The company said it would not pay a supplemental dividend for the quarter under its existing framework.
Income and NAV Drivers
Chief Financial Officer Gerhard Lombard said total investment income declined about $1.6 million sequentially. The reduction reflected lower dividend income and less realization activity, which led to lower accelerated amortization and prepayment-fee income.
Dividend income totaled $1.2 million, down approximately $1.8 million from the first quarter, primarily because of a lower distribution from the Logan joint venture as that vehicle continues to amortize and reduce leverage. Accelerated amortization and prepayment-fee income was about $0.4 million, compared with an average of roughly $0.8 million over the prior year.
Those factors were partly offset by higher interest income from positive net deployment during the first half of the year and restructurings of non-accrual investments, as well as lower management and incentive fees that became fully effective April 1.
Three restructurings completed during the quarter produced $0.48 per share of realized losses, Lombard said, but those losses were largely offset by the reversal of previously recognized unrealized losses. Separately, the company recorded $0.47 per share of unrealized losses, primarily from continued operating pressure among a subset of non-accrual investments. Realized gains contributed $0.03 per share, while the special dividend reduced NAV by another $0.03 per share.
Portfolio Performance and Watchlist
At quarter-end, Crescent Capital BDC held approximately $1.6 billion of investments at fair value across 192 portfolio companies. Senior first-lien loans represented 91% of the portfolio, while the average investment accounted for roughly 0.5% of total portfolio value.
President Henry Chung said the broader portfolio performed generally in line with underwriting expectations, with most portfolio companies reporting resilient operating results and year-over-year EBITDA growth. About 85% of investments were rated one or two, and the weighted-average portfolio risk rating was 2.1. Weighted-average interest coverage was stable at 2.2 times.
Still, the company’s watchlist rose modestly to 15% of the portfolio from 14% in the prior quarter. Chung said companies tied to deferrable consumer spending represented an outsized portion of watchlist investments. Healthcare investments were generally stable except for select company-specific situations, while software and services holdings continued to post stable operating results amid AI-related market volatility.
The company reported no new non-accruals during the quarter. Following three restructurings, non-accrual investments declined to 4.8% of debt investments at cost from 5.7% in the first quarter.
Management also continued rotating investments acquired through the legacy First Eagle portfolio. The acquired portfolio has been reduced from more than 70 investments to 27 investments, representing about 7% of CCAP’s portfolio at fair value as of June 30. During the quarter, the company restructured one legacy First Eagle investment and exited another acquired investment at par.
In response to an analyst question regarding eight consecutive quarters of NAV declines, Chung said the company marks watchlist and non-accrual investments based on current operating performance and near-term outlooks, which can change substantially from quarter to quarter. He said Crescent is focused on maximizing long-term recovery values rather than pursuing the fastest possible exits.
Leverage, Liquidity and Deployment
CCAP’s debt-to-equity ratio rose to 1.42 times, or 1.37 times after accounting for balance-sheet cash, due to lower NAV and positive net deployment. Lombard said the company ended the quarter above its long-term leverage target but had approximately $200 million of available borrowing capacity and $36 million in cash and cash equivalents.
The company expects several anticipated portfolio realizations to reduce leverage into its target net leverage range during the second half of 2026, all else equal.
- Repaid $162 million of maturing fixed-rate debt during the quarter.
- Increased its SPV asset facility by $100 million to $500 million.
- Expanded its SMBC corporate facility by $25 million to $335 million.
- Funded a previously committed $50 million tranche of 2025A fixed-rate unsecured notes due in May 2029.
Breaux said the company is intentionally balancing selective investment activity with the need to preserve financial flexibility. Gross deployment totaled $57 million, including $28 million across three new platform investments at weighted-average spreads of about 550 basis points. Follow-on investments accounted for the remaining $29 million. Exits, sales and repayments totaled approximately $36 million, producing net deployment of about $21 million.
Given its leverage position, Chung said the company expects near-term new positions to be smaller than its approximately 50-basis-point average portfolio position size, with the aim of adding diversification while maintaining access to the broader Crescent platform’s origination pipeline.
Breaux said sponsor-backed merger-and-acquisition activity remains below historical averages, though lending competition has improved as redemptions and slower capital formation in non-traded retail BDCs reduce competitive pressure. He added that Crescent’s broader platform committed more than $2.5 billion across private-credit transactions in the quarter and more than $8.7 billion over the past 12 months.
About Crescent Capital BDC (NASDAQ:CCAP)
Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.
The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.
